Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 24Terminated 7Recruiting 4Unknown 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Colorectal Neoplasms 37Carcinoma, Hepatocellular 14Ovarian Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Stomach Neoplasms 3Rectal Neoplasms 3Neoplasm Metastasis 3Glioblastoma 3Recurrence 2Liver Neoplasms 2Diabetes Mellitus, Insulin-Dependent, 12 2Brain Neoplasms 2mCRC 1Uterine Cervical Neoplasms 1Unresectable Metastatic Colorectal Cancer 1Spinocerebellar Degenerations 1Small Cell Lung Carcinoma 1Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma 1Rectal Neoplasms Malignant 1Proteinuria 1Platinum-sensitive Relapsed Ovarian Cancer 1Platinum-resistant Recurrent Ovarian Cancer (PROC) 1Platinum-resistant Recurrent Ovarian Cancer 1Osteosarcoma 1Non-small Cell Lung Cancer Patients with Brain Metastases 1Neutropenia 1Neoplastic Cells, Circulating 1NSCLC 1Metastatic Colorectal Cancer With Left-sided Primary Tumor 1Medulloblastoma 1

Interventions

aflutinib 2Pemetrexed 2lorlatinib 1anlotinib 1Platinum 1Orlistat 1Mastectomy, Segmental 1Diagnostic Imaging 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Adenocarcinoma of Lung × Bevacizumab × Clear all
NCT07416058 2026-02-17

PHOENIX

Guangdong Association of Clinical Trials

Phase 2 Not yet recruiting
61 enrolled
Thoracic

Diabetes Mellitus, Insulin-Dependent, 12, Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡